Role of perilipin 2 in microvascular obstruction in patients with ST-elevation myocardial infarction
Open Access
- 2 October 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 10 (6) , 633-642
Abstract
Coronary microvascular obstruction (MVO) occurs frequently in patients with ST-elevation myocardial infarction (STEMI) after percutaneous coronary intervention (PCI). However, mechanisms are multiple and not yet fully understood. Perilipin 2 (PLIN2) is involved in lipid metabolism of macrophages resident in atherosclerotic plaques, along with a role in enhancing plaque inflammation. We studied the association between PLIN2 and MVO in STEMI patients undergoing primary PCI, and we assessed the role of PLIN2 to predict major adverse cardiovascular events (MACEs). STEMI patients undergoing primary PCI were enrolled. PLIN2 was evaluated in peripheral blood monocytes; MVO was assessed using coronary angiogram. MACEs, as a composite of cardiac death, non-fatal myocardial infarction, re-admission for heart failure, and target vessel revascularization were investigated at follow-up. Among 100 STEMI patients, 33 (33.0%) had MVO. Patients with MVO had higher levels of PLIN2 (1.03 ± 0.28 vs. 0.90 ± 0.16, P = 0.019). Age [odds ratio (OR) (95% confidence interval, CI), 1.045 (1.005–1.087), P = 0.026] and PLIN2 [OR (95% CI), 16.606 (2.027–136.030), P = 0.009] were associated with MVO at univariate analysis, although only PLIN2 [OR (95% CI), 12.325 (1.446–105.039), P = 0.022] was associated with MVO at multivariate analysis. After a mean follow-up of 182.2 ± 126.6 days, 13 MACEs occurred. MVO [hazard ratio (HR) (95% CI), 6.791 (2.053–22.462), P = 0.002], hypercholesterolaemia [HR (95% CI), 3.563 (1.094–11.599), P = 0.035], and PLIN2 [HR (95% CI), 82.991 (9.857–698.746), P < 0.001] were predictors of MACEs at univariate analysis, although only PLIN2 [HR (95% CI), 26.904 (2.461–294.100), P = 0.007] predicted MACEs at multivariate analysis. In STEMI patients undergoing primary PCI, PLIN2 was independently associated with MVO and was an independent predictor of MACEs at follow-up, suggesting to further explore PLIN2 as a target for future cardioprotection therapies.Keywords
Funding Information
- Universitá Catttolica del Sacro Cuore
This publication has 33 references indexed in Scilit:
- Perilipin 2 (PLIN2)-Deficiency Does Not Increase Cholesterol-Induced Toxicity in MacrophagesPLOS ONE, 2012
- ADRP/ADFP and Mal1 expression are increased in macrophages treated with TLR agonistsAtherosclerosis, 2010
- Deficiency of Adipose Differentiation-Related Protein Impairs Foam Cell Formation and Protects Against AtherosclerosisCirculation Research, 2008
- Adipocyte differentiation-related protein is induced by LRP1-mediated aggregated LDL internalization in human vascular smooth muscle cells and macrophagesJournal of Lipid Research, 2007
- Adipophilin Expression Is Increased in Symptomatic Carotid AtherosclerosisStroke, 2007
- Genes of Cholesterol Metabolism in Human AtheromaArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Plaque Gruel of Atheromatous Coronary Lesion May Contribute to the No-Reflow Phenomenon in Patients With Acute Coronary SyndromeCirculation, 2002
- Angiographic Assessment of Myocardial Reperfusion in Patients Treated With Primary Angioplasty for Acute Myocardial InfarctionCirculation, 1998
- Comparison of coronary angiographic findings in acute and chronic first presentation of ischemic heart disease.Circulation, 1993
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985